STSeyda Gokce Turunc

Seyda Gokce Turunc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seyda Gokce Turunc has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamics of body composition in the treatment of locally advanced rectal cancer: the ımpact of adipose and muscle tissue on pathological response

    by Okan Dilek, Emin Demırel, Berkay Eyı, Seyda Gokce Turunc, Huseyin Akkaya, Zeynel Abidin Tas, Görkem Ozdemır, Timuçin Cıl, Gokhan Soker

    SUMMARY OBJECTIVE: The aim of the study was to evaluate the role of body composition parameters measured via computed tomography before and after neoadjuvant chemoradiotherapy in predicting pathological response in patients with locally advanced rectal cancer. METHODS: Eighty-four patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiotherapy followed by curative surgery were retrospectively analyzed. Computed tomography images obtained before and after neoadjuvant chemoradiotherapy were used to assess total adipose area, visceral adipose tissue, subcutaneous adipose tissue, adipose tissue density, psoas muscle area, psoas muscle density, and mesorectal adipose volume and density at the level of the L3 vertebra. Pathological response was determined using the Ryan Tumor Regression Grade system. Baseline values and percentage changes (Δ) during treatment were compared between response groups. RESULTS: Of the 84 patients, 31 (36.9%) showed a pathological response. There were no significant differences in demographic or clinical features between the groups. Among baseline body composition metrics, only psoas muscle density was significantly higher in the response group (p=0.015). Post-treatment analysis revealed a significant difference only in the percentage change in psoas muscle density (ΔPMD) (p=0.023). No other baseline or percentage change values for total adipose area, subcutaneous adipose tissue, visceral adipose tissue, mesorectal adipose volume, or psoas muscle area were significantly associated with pathological response (p>0.05). CONCLUSION: In patients with locally advanced rectal cancer, neither abdominal adipose composition nor mesorectal adipose volume nor psoas muscle area was predictive of response to neoadjuvant chemoradiotherapy. However, psoas muscle density, a potential indicator of muscle quality, may serve as a promising biomarker for predicting pathological response based on both baseline value and treatment-induced changes.

  • Open Access

    Duration of Ciprofloxacin Use Is Important in the Development of Abdominal Aortic Aneurysm in a Rat Model

    by Yekta Culpan, Irem Kececi, Irem Sandikci, Seyda Gokce, Hande Goker, Nagehan Ozyilmaz Yay, Rabia Ergelen, Dilek Akakin, Rezzan Gulhan

    Recent findings suggest that fluoroquinolones, most prescribed antibiotic to treat various infections, have increased abdominal aortic aneurysm formation. We aimed to investigate the relation of the development of abdominal aortic aneurysm and the duration of ciprofloxacin use. Male Sprague–Dawley rats were divided into 2 groups to administer saline to the control groups and CaCl2 to the aneurysm groups. These groups were then divided into 3 subgroups: intraperitoneal saline, ciprofloxacin for 2 weeks, and ciprofloxacin for 4 weeks. At the end of 4 weeks, the diameter of abdominal aorta was determined by ultrasonography and animals were sacrificed to obtain abdominal aorta specimens. Elastic fiber fracture, tunica media layer thickness, and aortic tissue damage were evaluated histologically. Aortic diameter of control-saline (2.15 mm ± 0.06), control-2 weeks (2.25 mm ± 0.06), and control-4 weeks (3.31 mm ± 0.09) ciprofloxacin groups was significantly different (P < .0001). Also, aortic diameter of aneurysm-saline (2.07 mm ± 0.02), aneurysm-2 weeks ciprofloxacin (3.33 mm ± 0.64), and aneurysm-4 weeks ciprofloxacin (8.55 mm ± 1.70) groups showed significant increase in aortic diameter with increasing duration of ciprofloxacin use (P < .01). A significant difference was found between the control-saline (0.00 ± 0.00), control-2 weeks (1.50 ± 0.33), and control-4 weeks ciprofloxacin groups (1.57 ± 0.20) in the histological aneurysm scores (P < .001). Aortic tunica media thickness did not change between control-saline and control-ciprofloxacin groups (P > .05). The study showed that ciprofloxacin caused injury in the aortic wall but not a significant change in the thickness of the aortic tunica media layer. The duration of ciprofloxacin use was important in the development of aneurysm and aneurysm severity.